Alkem Laboratories Limited
NSE: ALKEM | Information Technology
Market Fundamentals
Stock Intelligence & News
Sun Pharma, Alkem Labs, other pharma stocks gain despite stock market crash; Nifty Pharma rises for fourth day in a row
The Nifty Pharma index rose 1.4% on 8 June, defying the broader market selloff, supported by heavyweight stocks like JB Chemicals and Alkem Laboratories. Despite some losses in others, analysts suggest pharma stocks are resilient during market instability due to consistent healthcare demand.
Read Full Analysis →Alkem Laboratories shares decline over 1% after ₹930 crore promoter stake sale
The stock, which opened nearly flat, traded at ₹5,216.50 on the NSE after swinging between an intraday low of ₹5,175 and a high of ₹5,274
Read Full Analysis →Alkem Laboratories Limited
Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.". |SUBJECT: Press Release
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Get instant alerts when ALKEM breaks news
Join investors who track Alkem Laboratories Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for ALKEM?
ALKEM is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Alkem Laboratories Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding ALKEM to your custom watchlist.